匹地利珠单抗
Pidilizumab (Anti-PDCD1 / PD-1 / CD279)
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
1 mg 5 mg 10 mg 50 mg 100 mg
Product Availability
3-5days
Price
$800.00
Member price
Product Availability
3-5days
Price
$2300.00
Member price
Product Availability
3-5days
Price
$4200.00
Member price
Product Availability
3-5days
Price
$18500.00
Member price
Product Availability
3-5days
Price
$34000.00
Member price
Quantity
- +
Product Overview
Product Name Pidilizumab (Anti-PDCD1 / PD-1 / CD279)
CAS1036730-42-3
Security information
Product details

Pidilizumab (Anti-PDCD1 / PD-1 / CD279) is a humanized monoclonal antibody targeting human PD-1 (programmed cell death 1; PDCD1). It has immunomodulating and antitumor activities and can be used in treatment of metastatic melanoma. MW :144.48 KD.

Related literature
Related
Sorry, no related items
History
Reslizumab
Lebrikizumab (Anti-IL-13)
Brodalumab (anti-IL17RA)
Pidilizumab (Anti-PDCD1 / PD-1 / CD279)
Emibetuzumab (Anti-HGFR / c-Met)
Risankizumab (Synonyms: Risankizumab rzaa; BI 655066; ABBV-066)
Olokizumab (Anti-IL-6 / IFNb2)
Rilotumumab (Anti-HGF / SF)
Anti-Human PD-1 Monoclonal Antibody(Pembrolizumab biosimilar) mAb; MK-3475; Lambrolizumab
Silymarin